LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    Bioeconomy strategy sets the right pathway for Europe

    28/11/2025

    PRESS RELEASE

    Brussels, 28 November 2025 – “The Bioeconomy Strategy is a pivotal step towards strengthening Europe’s competitiveness, driving industrial decarbonisation, and fostering sustainable growth through innovation” says Claire Skentelbery, Director General of EuropaBio.

    EuropaBio welcomes a strong and explicit role for advanced fermentation and biorefineries in the Strategy with ambitious provisions, that include SME early advice and investment de-risking, in alignment with the strategy behind the EU Biotech Act.

    The new Strategy is a timely and essential pillar of the EU’s industrial policy, supporting the transition away from a petroleum-based society and aligning with key initiatives such as the EU Biotech Act, the Life Science Strategy, and the Clean Industrial Deal.

    EuropaBio supports the Commission’s ambition to build a reliable policy framework that attracts investment, enables sustainable growth, and unlocks the full potential of Europe’s bioeconomy. Biotechnologies are central to delivering the EU’s goals for competitive, healthy, resilient, and sustainable economies and societies.

    EuropaBio calls on the European Commission and Member States to ensure the Strategy delivers by supporting investment in biotech innovation, modernising regulatory frameworks to enable market access, and strengthening education and skills for the sector. These priorities will help unlock the full potential of Europe’s bioeconomy and secure its global competitiveness.

    Press Release - Bioeconomy strategy sets the right pathway for Europe


    Download
    Share
    Adrian Lincoln
    Adrian Lincoln

    Related posts

    06/03/2026

    Bene Meat Technologies joins EuropaBio: Advancing Cultivated Meat in Europe


    Read more
    13/02/2026

    The Association of Biopharmaceutical Manufacturers in Latvia (BRAL) joins EuropaBio: Promoting Access to Innovative Therapies


    Read more
    11/02/2026

    Call for tender: EU Biotech and Life Sciences Alliance MEP Group Secretariat services 2026


    Read more

    Important links

    • Bene Meat Technologies joins EuropaBio: Advancing Cultivated Meat in Europe
    • The Association of Biopharmaceutical Manufacturers in Latvia (BRAL) joins EuropaBio: Promoting Access to Innovative Therapies

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.